🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate the anti-pruritic efficacy and safety of Nalbuphine Extended...
Status
Completed
Location
Study Site 151
Start Date
2018-08-07
Trial ID
NCT03497975
Treatments Being Tested
This research study will evaluate the effect of hepatic impairment on the p...
Status
Completed
Location
01
Start Date
2019-06-12
Trial ID
NCT04020016
Treatments Being Tested
The primary purpose is to evaluate the safety and efficacy of NAL ER for th...
Status
Recruiting
Location
Pulmonary Specialists of The Palm Beaches
Start Date
2026-06-29
Trial ID
NCT07671911
To evaluate the safety and tolerability of nalbuphine ER tablets in the stu...
Status
Completed
Location
09
Start Date
2019-10-29
Trial ID
NCT04030026
The purpose of this study is to evaluate the efficacy and safety of Nalbuph...
Status
Recruiting
Location
Dynamic Drug Advancement Ltd
Start Date
2026-06-22
Trial ID
NCT07671924
The purpose of this study is to measure the effects of a drug called nalbup...
Status
Completed
Location
001
Start Date
2018-05-29
Trial ID
NCT04018664
Treatments Being Tested
The main purpose of this study is to evaluate the effect of NAL ER on 24-ho...
Status
Completed
Location
McMaster University Medical Centre
Start Date
2023-11-30
Trial ID
NCT05962151
The primary purpose of this study is to assess the safety and tolerability ...
Status
Completed
Location
Mayo Clinic
Start Date
2025-08-21
Trial ID
NCT07036029
The main purpose of the study is to evaluate the effect of NAL ER on 24-hou...
Status
Completed
Location
Eastern Health-Box Hill Hospital
Start Date
2024-02-06
Trial ID
NCT05964335
The primary purpose of this study is to evaluate the effect of a high-fat, ...
Status
Completed
Location
Clinical Pharmacology of Miami, LLC.
Start Date
2026-02-27
Trial ID
NCT07487740
Treatments Being Tested